Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bone Marrow Transplant ; 24(5): 463-6, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10482928

ABSTRACT

Harvesting of peripheral blood stem cells (PBSCs) following chemotherapy and G-CSF administration is currently performed for hematological therapies. However, a procedure based on the use of a large quantity of G-CSF is relatively costly. Therefore, we retrospectively compared the effects of two PBSC mobilization procedures in a population with recently diagnosed multiple myeloma. The first procedure consisted of chemotherapy and systematic G-CSF administration (group 1: 24 patients). The second consisted of chemotherapy alone, G-CSF having been administered only in the case of failure of PBSC mobilization or delayed white blood cell (WBC) recovery (group 2: 28 patients). Leukapheresis was performed when WBC recovery reached 1 x 10(9)/l if the peripheral blood CD34+ cell count was over 10/microl. Leukapheresis was maintained until a total of 2.5 x 10(6) CD34+ cells/kg was harvested. A significant difference was observed between the two groups only in regard to the median period of WBC recovery (delayed for group 2) and the number of CD34+ cells/kg collected on the first leukapheresis (higher for group 1) but not to the proportion of patients with failure of PBSC collection. Ten group 2 patients, who had insufficient CD34+ cells after WBC recovery or delayed WBC recovery, received G-CSF which resulted in sufficient PBSC harvesting in nine. To obtain a sufficient CD34+ cell level, the patients without systematic G-CSF administration had more leukaphereses (2.1 vs 1.5) but the mean consumption of G-CSF per patient was eight times less than in the other group. Nonsystematic use of G-CSF before WBC recovery or preferentially its introduction just after, could be an interesting economical alternative in PBSC mobilization but should be assessed by a prospective controlled study of cost/efficacy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Blood Cells , Granulocyte Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cell Mobilization/methods , Hematopoietic Stem Cells , Leukapheresis , Multiple Myeloma/blood , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Cyclophosphamide/pharmacology , Doxorubicin/administration & dosage , Doxorubicin/pharmacology , Drug Administration Schedule , Evaluation Studies as Topic , Female , Hematopoietic Stem Cell Mobilization/economics , Hematopoietic Stem Cells/drug effects , Humans , Male , Middle Aged , Multiple Myeloma/drug therapy , Multiple Myeloma/therapy , Prednisone/administration & dosage , Prednisone/pharmacology , Retrospective Studies , Vincristine/administration & dosage , Vincristine/pharmacology
2.
Radiat Res ; 149(2): 128-33, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9457891

ABSTRACT

The formation and decay of HO2/O2- radical from the radiolysis of water by heavy 36S16+ ions (2.7 GeV) have been observed by time-resolved absorption spectroscopy at 260 nm. The experiment was performed at the Grand Accélérateur National d'Ions Lourds (Caen, France). In deaerated water, for a linear energy transfer (LET) of 250 eV/nm, the yield of HO2/O2- is (6 +/- 2) x 10(-9) mol J-1. In aerated solution, an additional formation of O2- is observed due to the reaction of hydrogen atom and e(aq)- with oxygen. The experimental G values are compared to those obtained with light ions for the same LET. The importance of the initial velocity is discussed briefly.


Subject(s)
Superoxides/chemistry , Water/chemistry , Dose-Response Relationship, Radiation , Free Radicals , Hydrogen-Ion Concentration , Linear Energy Transfer , Particle Accelerators , Radiation Effects , Radiochemistry , Sulfur
SELECTION OF CITATIONS
SEARCH DETAIL
...